3 research outputs found
Effectiveness of combined treatment with pegylated interferon \alpha-2a and ribavirin in chronic hepatitis C : study phase summary
Safety and tolerability of the combination therapy with pegylated interferon alfa-2a (Pegasys庐) and ribavirin (Copegus庐) in patients with chronic hepatitis C in Poland : interim analysis of data from EAP program
sPECAM-1 and sVCAM-1: Role in Pathogenesis and Diagnosis of Chronic Hepatitis C and Association with Response to Antiviral Therapy
Aim: To analyze the relationship between pretreatment clinical or
histological features and the levels of soluble platelet-endothelial cell
adhesion molecule-1 (sPECAM-1) and soluble vascular cell adhesion molecule-1
(sVCAM-1), to determine their serum concentration in responders and
nonresponders, to evaluate the behavior under antiviral therapy, to explain
their relationship in response to therapy and to assess the association between
these two molecules in chronic hepatitis C (CHC)